Immunotherapy and GI cancer. Learnings from the ESMO Congress 2024, ESMO Immuno-Oncology Congress 2024 and Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 by SPCC will be held at December 17th, 2024. Join this
Haemato-oncology highlights from 66th ASH Annual Meeting by SPCC will be held at December 18, 2024. This live webinar serves as a crucial platform for oncologists to stay informed about the latest research and breakthroughs
LATAM Course II: Immunotherapy in Lung Cancer by IASLC will be held at December 19, 2024. This exclusive Live Course on the latest updates in lung cancer treatment, specifically focusing on immunotherapy, offers a deep
LATAM Course II: Immunotherapy in Lung Cancer by IASLC will be held at December 19th, 2024. The exclusive course on the latest updates in lung cancer treatment in LATAM, with a special focus on immunotherapy,
Breast cancer highlights from the San Antonio Breast Cancer Symposium 2024 by SPCC will be held at December 19, 2024. This live webinar will start with an introduction by Nadia Harbeck from Germany, setting the
Eastern Europe and Baltic Course I: Immunotherapy in Lung Cancer by IASLC will be held at December 30, 2024. This Exclusive Virtual Course focuses on the latest updates in lung cancer treatment in Eastern Europe
The 17th BGICC 2025 (Breast, Gynecological and Immuno-oncology International Cancer Conference) is a premier event in the field of oncology, widely recognized as the largest and most prestigious cancer conference in both Africa and the
The ASCO Gastrointestinal Cancers 2025 Symposium, happening on January 23-25 in Moscone West, San Francisco, will bring together top experts in gastrointestinal oncology. Attendees can look forward to insightful keynote talks, engaging panel discussions, and
HEAL webinar series on the health impacts of per- and polyfluoroalkyl substances will be held on 23 January 2024 at 15:00 CET. The HEAL Virtual Webinar Series on PFAS and Human Health is a crucial
The AACR Special Conference in Cancer Research: Translating Targeted Therapies in Combination with Radiotherapy, will be taking place at the Hilton San Diego Bayfront, on January 26-29, 2025. This conference will explore the future of
13th AACR-JCA Joint Conference will be held from February 1-3, 2025 at Maui, Hawaii. The 13th AACR-JCA Joint Conference is a significant event hosted by the American Association for Cancer Research (AACR) in collaboration with
AACR Special Conference in Cancer Research: DNA Methylation, Clonal Hematopoiesis, and Cancer will be held from February 1-4, 2025. The upcoming AACR Special Conference, chaired by Stephen Baylin, Margaret Goodell, and Peter Jones will focus
